Brandon Joel Zipp Form 3 Vitality Biopharma / Brandon Joel Zipp ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Zipp Brandon Joel

(Last) (First) (Middle)

1901 AVENUE OF THE STARS, 2ND FLOOR

(Street)

LOS ANGELES, CA 90067

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
09/24/2020

3. Issuer Name and Ticker or Trading Symbol
Vitality Biopharma, Inc. [ VBIO ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Chief Science Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock, par value $0.001 per share	14,000	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	03/11/2013	03/11/2023	Common Stock, par value $0.001 per share	2,500	4.2	D
Employee Stock Option (Right to Buy)	03/12/2013	03/12/2023	Common Stock, par value $0.001 per share	7,500	4.4	D
Employee Stock Option (Right to Buy)	04/03/2014	04/03/2024	Common Stock, par value $0.001 per share	15,000	4.2	D
Employee Stock Option (Right to Buy)	01/01/2015	01/01/2025	Common Stock, par value $0.001 per share	20,000	3.4	D
Employee Stock Option (Right to Buy)	05/21/2015	05/21/2025	Common Stock, par value $0.001 per share	20,000	2.1	D
Employee Stock Option (Right to Buy)	07/18/2016	07/18/2026	Common Stock, par value $0.001 per share	370,234	0.5	D
Employee Stock Option (Right to Buy)	12/27/2017	12/27/2027	Common Stock, par value $0.001 per share	75,000	1.81	D
Employee Stock Option (Right to Buy)(1)	05/08/2019	05/08/2029	Common Stock, par value $0.001 per share	500,000	0.35	D

Explanation of Responses:

1. Option was granted on May 8, 2019. Vested as to 250,000 shares on May 8, 2020. Option on remaining 250,000 shares vests on May 8, 2021.

	/s/ Brandon Zipp	10/23/2020
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.